Psychological Outcomes

How it works

Benefits

Highlighted claims

• The study aims to reduce anxiety, depression, and perceived distress while improving quality of life for early-stage breast cancer patients. — Protocol for the development and testing of a web-based patient decision aid for early-stage breast cancer patients within a cancer centre care: a mixed-method approach
• Depression, anxiety, psychological distress, and quality of life will be measured using validated instruments including the PHQ-9, STAI, Distress Thermometer, and EORTC questionnaires. — Protocol for the development and testing of a web-based patient decision aid for early-stage breast cancer patients within a cancer centre care: a mixed-method approach
• Breast cancer-specific quality of life will be assessed using the EORTC QLQ-BR23, which covers body image, sexual functioning, systemic therapy side effects, breast symptoms, and arm symptoms. — Protocol for the development and testing of a web-based patient decision aid for early-stage breast cancer patients within a cancer centre care: a mixed-method approach
• The intervention is expected to produce lower anxiety, depression, and psychological distress due to the decision aid's informational content. — Protocol for the development and testing of a web-based patient decision aid for early-stage breast cancer patients within a cancer centre care: a mixed-method approach
• Anxiety, depression, and psychological distress are expected to decrease more rapidly in the intervention group than in the control group across the three assessment periods. — Protocol for the development and testing of a web-based patient decision aid for early-stage breast cancer patients within a cancer centre care: a mixed-method approach